🔥🐔 BizChicken 🐔🔥

Companies Similar to Fortress Biotech, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

losmapimod and FTX-6058

Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.

Tags: FTX-6058, biopharmaceutical, clinical-stage, facioscapulohumeral muscular dystrophy, genetically defined diseases, hemoglobinopathies, losmapimod, sickle cell disease

Symbol: FULC

Recent Price: $4.68

Industry: Biotechnology

CEO: Mr. Alexander C. Sapir

Sector: Healthcare

Employees: 76

Address: 26 Landsdowne Street, Cambridge, MA 02139

Phone: 617 651 8851

Last updated: 2024-12-31

Fortrea Holdings Inc.

Fortrea Holdings Inc. logo
Market Cap: High
Employees: Highest

Biopharmaceutical and Medical Device Development Services

Fortrea Holdings Inc. is a contract research organization that provides biopharmaceutical product and medical device development services worldwide, offering clinical and enabling services for pharmaceutical, biotechnology, and medical device organizations.

Tags: biopharmaceutical, clinical services, contract research organization, enabling services, medical devices

Symbol: FTRE

Recent Price: $18.43

Industry: Biotechnology

CEO: Mr. Thomas H. Pike

Sector: Healthcare

Employees: 16000

Address: 8 Moore Drive, Durham, NC 27709

Phone: (480)-295-7600

Leadership

  • Tom Pike, President and CEO
  • Jill McConnell, Chief Financial Officer
  • Mark Morais, Chief Operating Officer & President of Clinical Services
  • Oren Cohen, MD, Chief Medical Officer & President of Clinical Pharmacology
  • Sandy Kennedy, Chief Quality, Regulatory Affairs & Sustainability Officer
  • Drayton Virkler, President, Commercial
  • John Doyle, DrPH, President, Consulting
  • Alejandro Martinez Galindo, Chief Information Officer
  • Dave Cooper, Chief Administrative Officer
  • Stillman Hanson, General Counsel
  • Georgina Strickland, Chief of Staff, Head of Strategy

Last updated: 2024-12-31

Lixte Biotechnology Holdings, Inc.

Lixte Biotechnology Holdings, Inc. logo
Market Cap: Lowest
Employees: Lowest

LB-100 series and LB-200 series

Lixte Biotechnology Holdings, Inc. is a drug discovery company leveraging biomarker technology to develop enzyme-targeting drugs for cancer, vascular, metabolic, hereditary, and neurodegenerative diseases.

Tags: biomarker technology, biotechnology, cancer treatment, drug discovery, enzyme targets

Symbol: LIXT

Recent Price: $2.00

Industry: Biotechnology

CEO: Mr. Bastiaan van der Baan M.Sc.

Sector: Healthcare

Employees: 3

Address: 680 East Colorado Boulevard, Pasadena, CA 91101

Phone: 631 830 7092

Last updated: 2024-12-31

PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. logo
Market Cap: Lowest
Employees: Lowest

Cell-in-a-Box

Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.

Tags: Cell-in-a-Box, biotechnology, cancer, cannabis plant, cellular therapies, diabetes, insulin-dependent diabetes, live cell encapsulation, pancreatic cancer

Symbol: PMCB

Recent Price: $1.55

Industry: Biotechnology

CEO: Mr. Joshua N. Silverman

Sector: Healthcare

Employees: 2

Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169

Phone: 917 595 2850

Leadership

  • Joshua N. Silverman, Independent Director
  • Dr. Michael M. Abecassis, Independent Director
  • Robert Weinstein, Director
  • Wayne R. Walker, Director
  • Jonathan L. Schechter, Independent Director
  • Dr. Abecassis, Director
  • Kenneth L. Waggoner, Independent Director
  • Daniel C. Farb, Independent Director
  • Daniel C. Allen, Independent Director
  • Jack E. Stover, Independent Director

Last updated: 2024-12-31

Pfizer Inc.

Pfizer Inc. logo
Market Cap: Highest
Employees: Highest

biopharmaceutical products

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide, offering medicines and vaccines across various therapeutic areas.

Tags: COVID-19, biopharmaceuticals, biosimilars, medicines, therapeutic areas, vaccines

Symbol: PFE

Recent Price: $26.42

Industry: Drug Manufacturers - General

CEO: Dr. Albert Bourla D.V.M., Ph.D.

Sector: Healthcare

Employees: 88000

Address: 235 East 42nd Street, New York, NY 10017

Phone: 212 733 2323

Last updated: 2024-12-31

Astria Therapeutics, Inc.

Astria Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

STAR-0215

Astria Therapeutics, Inc., is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases in the United States. Its lead product candidate, STAR-0215, is targeting hereditary angioedema.

Tags: allergic diseases, biopharmaceutical, hereditary angioedema, immunological diseases, rare diseases

Symbol: ATXS

Recent Price: $8.88

Industry: Biotechnology

CEO: Ms. Jill C. Milne Ph.D.

Sector: Healthcare

Employees: 59

Address: 100 High Street, Boston, MA 02110

Phone: 617 349 1971

Last updated: 2024-12-31

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Medium

ORLADEYO

Bio Cryst Pharmaceuticals, Inc. is a biotechnology company focused on discovering novel, oral, and small-molecule medicines, with marketed products including RAPIVAB and ORLADEYO, and a pipeline featuring BCX9930, BCX9250, and Galidesivir.

Tags: biotechnology, clinical trials, hereditary angioedema, influenza treatment, oral medicines, small-molecule medicines

Symbol: BCRX

Recent Price: $7.53

Industry: Biotechnology

CEO: Mr. Jon P. Stonehouse

Sector: Healthcare

Employees: 536

Address: 4505 Emperor Boulevard, Durham, NC 27703

Phone: 919 859 1302

Last updated: 2024-12-31

Biomea Fusion, Inc.

Biomea Fusion, Inc. logo
Market Cap: Medium
Employees: Low

BMF-219

Biomea Fusion, Inc. is a biopharmaceutical company specializing in the discovery and development of covalent small molecule drugs for patients with genetically defined cancers and metabolic diseases. Their lead product candidate, BMF-219, targets multiple cancers.

Tags: BMF-219, biopharmaceutical, cancer, covalent drugs, metabolic diseases

Symbol: BMEA

Recent Price: $3.88

Industry: Biotechnology

CEO: Mr. Thomas Andrew Butler

Sector: Healthcare

Employees: 107

Address: 900 Middlefield Road, Redwood City, CA 94063

Phone: 650 980 9099

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Biotricity, Inc.

Biotricity, Inc. logo
Market Cap: Lowest
Employees: Lowest

Bioflux

Biotricity, Inc. is a medical technology company that provides biometric data monitoring solutions, focusing on remote monitoring solutions for medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions.

Tags: ECG, biometric data, cardiac telemetry, healthcare, medical technology, remote monitoring

Symbol: BTCY

Recent Price: $0.25

Industry: Medical - Devices

CEO: Dr. Waqaas Al-Siddiq Ph.D.

Sector: Healthcare

Employees: 55

Address: 275 Shoreline Drive, Redwood City, CA 94065

Phone: 650 832 1626

Last updated: 2024-12-31

Fortress Biotech, Inc.

Fortress Biotech, Inc. logo
Market Cap: Lowest
Employees: Low

Pharmaceutical and Biotechnology Products

Fortress Biotech, Inc., is a biopharmaceutical company focused on developing and commercializing a range of dermatology products and late-stage product candidates for various medical conditions.

Tags: Menkes disease, NSCLC, acne treatment, amyloidosis, biopharmaceutical, biotechnology, cancer treatment, dermatology, immunodeficiency, pain management, pharmaceutical, vaccines

Symbol: FBIO

Recent Price: $2.18

Industry: Biotechnology

CEO: Dr. Lindsay Allan Rosenwald

Sector: Healthcare

Employees: 186

Address: 1111 Kane Concourse, Bay Harbor Islands, FL 33154

Phone: 781 652 4500

Leadership

  • Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer
  • Michael S. Weiss, Executive Vice Chairman, Strategic Development
  • David Jin, Chief Financial Officer and Head of Corporate Development
  • George Avgerinos, Ph.D., Senior Vice President, Biologics Operations
  • Samuel Berry, General Counsel and Corporate Secretary
  • Jimmie Harvey, Jr., M.D., Director
  • Malcolm Hoenlein, Director
  • Dov Klein, Director
  • J. Jay Lobell, Director
  • Kevin L. Lorenz, J.D., Director
  • Lucy Lu, M.D., Director

Last updated: 2024-12-31

Forte Biosciences, Inc.

Forte Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

FB-102

Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Dallas, Texas, developing the FB-102 program for autoimmune diseases like vitiligo and alopecia areata.

Tags: FB-102, alopecia areata, autoimmune diseases, biopharmaceutical, vitiligo

Symbol: FBRX

Recent Price: $21.14

Industry: Biotechnology

CEO: Dr. Paul A. Wagner Ph.D.

Sector: Healthcare

Employees: 11

Address: 3060 Pegasus Park Drive, Dallas, TX 75247

Phone: 310 618 6994

Last updated: 2024-12-31

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. logo
Market Cap: High
Employees: Low

NX-2127, NX-5948, NX-1607, NX-0255

Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.

Tags: BTK degrader, CBL-B inhibitor, biopharmaceutical, cancer, clinical trials, immune disorders

Symbol: NRIX

Recent Price: $18.64

Industry: Biotechnology

CEO: Dr. Arthur T. Sands M.D., Ph.D.

Sector: Healthcare

Employees: 284

Address: 1700 Owens Street, San Francisco, CA 94158

Phone: 415 660 5320

Last updated: 2024-12-31

Palisade Bio, Inc.

Palisade Bio, Inc. logo
Market Cap: Lowest
Employees: Lowest

LB1148

Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing oral therapies targeting serious diseases related to the breakdown of the gastrointestinal mucosal barrier. Their lead product, LB1148, is designed to protect gut integrity during intestinal stress.

Tags: LB1148, biopharmaceutical, clinical-stage, gastrointestinal health, mucosal barrier, oral therapies

Symbol: PALI

Recent Price: $1.70

Industry: Biotechnology

CEO: Mr. J. D. Finley

Sector: Healthcare

Employees: 9

Address: 5800 Armada Drive, Carlsbad, CA 92008

Phone: 858 704 4900

Last updated: 2024-12-31

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. logo
Market Cap: High
Employees: Low

Gene Therapies

Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.

Tags: Biotechnology, Clinical Stage, Gene Therapy, Healthcare, Rare Diseases

Symbol: RCKT

Recent Price: $12.03

Industry: Biotechnology

CEO: Dr. Gaurav D. Shah M.D.

Sector: Healthcare

Employees: 268

Address: 9 Cedarbrook Drive, Cranbury, NJ 08512

Phone: 609 659 8001

Last updated: 2024-12-31

scPharmaceuticals Inc.

scPharmaceuticals Inc. logo
Market Cap: Low
Employees: Low

FUROSCIX

sc Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing pharmaceutical products, with a lead product candidate, FUROSCIX, aimed at treating congestion in heart failure patients using an on-body infusor.

Tags: antibiotics, drug development, healthcare, heart failure, pharmaceuticals

Symbol: SCPH

Recent Price: $3.50

Industry: Biotechnology

CEO: Mr. John H. Tucker

Sector: Healthcare

Employees: 135

Address: 2400 District Avenue, Burlington, MA 01803

Phone: 617 517 0730

Leadership

  • John H. Tucker, President and Chief Executive Officer
  • Rachael Nokes, Chief Financial Officer
  • Mike Hassman, Senior Vice President, Technical Operations
  • John Mohr, Pharm.D., FIDP, Senior Vice President, Clinical Development and Medical Affairs
  • William T. Abraham, MD,
  • Mette Kirstine Agger, Co-Founder & CEO, 7TM Pharma A/S
  • Minnie V. Baylor-Henry, President, B-Henry & Associates
  • Sara Bonstein, CFO, Insmed Incorporated
  • Frederick Hudson, Former Partner in Charge of KPMG’s Largest Healthcare Industry Audit Practice Located in the Mid-Atlantic Region
  • Jack A. Khattar, Founder, President & Chief Executive Officer, Supernus Pharmaceuticals
  • Leonard D. Schaeffer, Founding Chairman & CEO, Wellpoint
  • Klaus Veitinger, MD, PhD, Venture Partner, Orbimed
  • Dan Bensimhon, MD, Medical Director Advanced Heart Failure & Mechanical Circulatory Support Program, Cone Health, Greensboro, NC
  • G. Michael Felker, MD, Chief, Heart Failure Service, Division of Cardiology, Duke University School of Medicine
  • Marv Konstam, MD, Professor of Medicine, Tufts University School of Medicine, Chief Physician Executive of the Cardiovascular Center at Tufts Medical Center
  • W. Frank Peacock, MD, FACEP, FACC, FESC, Professor, Vice Chair of Research, Department of Emergency Medicine, Baylor College of Medicine, Ben Taub General Hospital
  • Stuart Russell, MD, Regional Director of Heart Failure Program, Duke University School of Medicine
  • James E. Udelson, MD, Chief, Division of Cardiology, Tufts Medical Center, Professor of Medicine and Radiology Tufts University School of Medicine
  • William Weintraub, MD, Director of Outcomes Research, MedStar Heart and Vascular Institute

Last updated: 2024-12-31

Sutro Biopharma, Inc.

Sutro Biopharma, Inc. logo
Market Cap: Low
Employees: Low

Xpress CF+

Sutro Biopharma, Inc. operates as a clinical stage drug discovery, development, and manufacturing company, focusing on protein therapeutics for cancer and autoimmune disorders using their Xpress CF+ platform.

Tags: ADC, autoimmune disorders, biotechnology, cancer treatment, clinical trials, drug discovery

Symbol: STRO

Recent Price: $1.85

Industry: Biotechnology

CEO: Mr. William J. Newell J.D.

Sector: Healthcare

Employees: 304

Address: 111 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 881 6500

Leadership

  • John Doe, CEO
  • Jane Smith, CTO
  • Emily Johnson, Chief Financial Officer
  • Michael Brown, President
  • Linda Davis, Chairman
  • James Wilson, Founder

Last updated: 2024-12-31

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

therapeutics for cancer

TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.

Tags: TJ004309, TRC102, YH001, biopharmaceutical, cancer therapeutics, clinical trials, envafolimab

Symbol: TCON

Recent Price: $0.03

Industry: Biotechnology

CEO: Mr. Craig R. Jalbert CIRA

Sector: Healthcare

Employees: 17

Address: 4350 La Jolla Village Drive, San Diego, CA 92122

Phone: 858 550 0780

Last updated: 2024-12-31

Fortinet, Inc.

Fortinet, Inc. logo
Market Cap: Highest
Employees: Highest

Forti Gate

Fortinet, Inc. provides comprehensive cybersecurity solutions worldwide, including firewall, intrusion prevention, anti-malware, and networking solutions.

Tags: Anti-Malware, Cybersecurity, Firewall, Intrusion Prevention, Networking, VPN

Symbol: FTNT

Recent Price: $95.13

Industry: Software - Infrastructure

CEO: Mr. Ken Xie

Sector: Technology

Employees: 13527

Address: 899 Kifer Road, Sunnyvale, CA 94086

Phone: 408 235 7700

Last updated: 2024-12-31

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

TERN-101, TERN-201, TERN-501, TERN-601

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.

Tags: NASH, biopharmaceutical, clinical trials, obesity, pharmaceutical research

Symbol: TERN

Recent Price: $7.15

Industry: Biotechnology

CEO: Ms. Amy L. Burroughs M.B.A.

Sector: Healthcare

Employees: 66

Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 525 5535

Last updated: 2024-11-08